Related Experiment Video
Updated: Mar 28, 2026

10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
8.1K
A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure
1School of Life Sciences, Central University of Himachal Pradesh, Kangra, Himachal Pradesh 176206, India.
Immunobiology
|December 29, 2015
Summary
Conventional vaccines failed against Mycobacterium avium subsp. paratuberculosis (MAP). A novel multi-epitope subunit vaccine was designed using protein structure, combining MAP epitopes with a TLR4 agonist adjuvant for enhanced immune response against MAP infections.
Area of Science:
- Vaccinology
- Immunology
- Computational Biology
Background:
- Conventional vaccines show limited efficacy in preventing Mycobacterium avium subsp. paratuberculosis (MAP) infections and their spread.
- Protein structure-based vaccine design offers a promising alternative to traditional approaches.
- Developing effective subunit vaccines requires careful selection and combination of antigenic components and adjuvants.
Purpose of the Study:
- To design and computationally evaluate a novel multi-epitope subunit vaccine against MAP.
- To enhance vaccine stability and immunogenicity through protein engineering and molecular dynamics simulations.
- To create a vaccine candidate that elicits robust cellular and humoral immune responses.
Main Methods:
- Conjugation of immunodominant peptide epitopes from MAP1611 with heparin-binding hemagglutinin (a TLR4 agonist) as an adjuvant.
- 3D homology modeling to generate the chimeric multi-epitope vaccine structure.
- Molecular dynamics simulations and disulfide engineering to assess and enhance conformational stability and identify optimal mutants.
Main Results:
- A stable, multi-epitope subunit vaccine construct was designed, incorporating T-cell and B-cell epitopes.
- Disulfide engineering yielded a double mutant (Q631C-A634C/Y593C-E610C) with enhanced thermodynamic stability.
- The final vaccine candidate is predicted to be antigenic, soluble, non-allergenic, and capable of interacting with TLR receptors.
Conclusions:
- The designed multi-epitope subunit vaccine, particularly the double mutant, shows significant potential for inducing protective Th1 cellular and humoral immunity against MAP.
- This protein structure-based strategy represents a promising platform for developing pathogen-specific vaccines.
- The approach may be adaptable for combating other infectious diseases in the future.
Keywords:
Disulfide engineeringEpitopeImmunoinformaticsMolecular dynamics simulationsMulti-subunit vaccine modelMycobacterium avium subsp. paratuberculosisMore Related Videos
Related Concept Videos
Vaccines
41
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
41
Antibody Structure
67.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
67.4K
Protein Complex Assembly
17.1K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
17.1K
Vaccine Production
57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
Protein Complexes with Interchangeable Parts
3.1K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.1K

